In this podcast, expert clinicians will discuss the latest clinical trial data, including the efficacy and safety, of gene therapies for retinal diseases.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.5 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 6900 Grove Road
Pricing
100% of listed courses are free
259 of 259 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Rhinology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Podcast / audio
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedOct 31, 2025
-
Last day to claim creditOct 31, 2026 3 weeks left
-
Vindico Medical Education, LLC The Retina Radar With Dr. Arshad Khanani on Rare Retinal Diseases, Biosimilars, and Gene Therapy in 2025
-
Vindico Medical Education, LLC The Retina Radar With Dr. Arshad Khanani: Emerging Therapeutics for Rare Retinal Diseases With Dr. Christina Kay
-
Vindico Medical Education, LLC The Retina Radar With Dr. Arshad Khanani: Tyrosine Kinase Inhibitors in 2025 With Drs. Chang and Emanuelli
-
Paradigm Medical Communications, LLC The Many Faces of Neovascular Retinal Disease: Individualizing the Use of Sustained Delivery Therapy
-
Impact Education +1 Advanced Clinical Updates in Retinal Diseases for Managed Care Professionals
-
Answers in CME Inc. (AiCME) Bridging Clinical Trial and Real-World Evidence in Retinal Diseases: Updated Strategies With Anti-VEGF Therapies
